1.4600
+0.0500
+(3.55%)
At close: April 17 at 4:00:00 PM EDT
1.4001
-0.06
(-4.10%)
After hours: April 17 at 6:58:15 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 3 |
| Avg. Estimate | 600.25k | 608.25k | 2.38M | 2.83M |
| Low Estimate | 578k | 600k | 2.18M | 1.85M |
| High Estimate | 623k | 630k | 2.51M | 4M |
| Year Ago Sales | 548k | 468k | 2.39M | 2.38M |
| Sales Growth (year/est) | 9.53% | 29.97% | -0.69% | 19.13% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -2.01 | -0.87 | -0.44 | -0.36 |
| EPS Actual | -1.61 | -1.83 | -0.34 | -- |
| Difference | 0.39 | -0.96 | 0.1 | -- |
| Surprise % | 19.70% | -110.34% | 23.31% | -- |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| LGVN | -- | -- | -- | -- |
| S&P 500 | 6.92% | 5.09% | 8.78% | 14.15% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/21/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/3/2025 |
| Initiated | Roth MKM: Buy | 12/5/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/25/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/4/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 9/4/2024 |
Related Tickers
ENSC Ensysce Biosciences, Inc.
1.7600
-6.38%
KTTA Pasithea Therapeutics Corp.
1.3800
+0.73%
VRAX Virax Biolabs Group Limited
0.9935
-3.54%
PALI Palisade Bio, Inc.
0.7199
+2.80%
REVB Revelation Biosciences, Inc.
3.0800
+2.67%
WINT Windtree Therapeutics, Inc.
1.1400
+0.88%
BDRX Biodexa Pharmaceuticals Plc
1.4300
-0.69%
PXMD PaxMedica, Inc.
0.0001
0.00%
TVGN Tevogen Bio Holdings Inc.
0.9796
-3.96%
ZVSA ZyVersa Therapeutics, Inc.
0.6991
-1.89%